Ana Cristina Freire is a prominent inventor based in Northampton, GB. She has made significant contributions to the field of pharmaceutical formulations, particularly in the development of delayed release drug formulations. With a total of six patents to her name, her work has the potential to enhance drug delivery systems and improve patient outcomes.

Latest Patents

One of her latest patents focuses on a delayed release drug formulation that includes a core containing a drug and a delayed release coating designed for intestinal release. This innovative formulation accelerates the release of the drug in the colon by incorporating an isolation layer between the core and the delayed release coating. The coating consists of an inner layer and an outer layer. The outer layer is made from a pH dependently soluble polymeric material with a pH threshold of about 5 or above. The inner layer is composed of a soluble polymeric material that is soluble in intestinal or gastrointestinal fluid. This material is selected from a group that includes a polycarboxylic acid polymer that is at least partially neutralized and a non-ionic polymer. In cases where the soluble polymeric material is a non-ionic polymer, the inner layer also includes at least one additive selected from a buffer agent and a base.

Career Highlights

Ana Cristina Freire has established herself as a key figure in her field through her innovative research and development efforts. She is currently employed at Tillotts Pharma AG, where she continues to work on advancing drug formulation technologies. Her expertise and dedication have led to the successful patenting of multiple formulations that address critical needs in the pharmaceutical industry.

Collaborations

Throughout her career, Ana has collaborated with notable professionals in her field, including Thomas Buser and Abdul Waseh Basit. These collaborations have further enriched her research and contributed to the success of her innovative projects.

Conclusion

Ana Cristina Freire is a trailblazer in the realm of pharmaceutical innovations, particularly in delayed release drug formulations. Her contributions are poised to make a lasting impact on drug delivery systems and patient care.

This text is generated by artificial intelligence and may not be accurate.